Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms, Experimental | 6 | 2015 | 28 | 1.270 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2021 | 9 | 0.840 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2021 | 15 | 0.830 |
Why?
|
| Antigens, Neoplasm | 4 | 2007 | 57 | 0.730 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2021 | 12 | 0.720 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2017 | 134 | 0.700 |
Why?
|
| Peptides | 4 | 2021 | 297 | 0.570 |
Why?
|
| Gastroschisis | 1 | 2018 | 6 | 0.570 |
Why?
|
| Meconium Aspiration Syndrome | 2 | 2010 | 5 | 0.560 |
Why?
|
| Hyperventilation | 1 | 2017 | 4 | 0.530 |
Why?
|
| Ape Diseases | 1 | 2017 | 4 | 0.530 |
Why?
|
| Apnea | 1 | 2017 | 13 | 0.530 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 27 | 0.530 |
Why?
|
| Propofol | 1 | 2017 | 10 | 0.530 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 44 | 0.530 |
Why?
|
| Anesthetics, Intravenous | 1 | 2017 | 15 | 0.530 |
Why?
|
| Papio anubis | 1 | 2017 | 48 | 0.520 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2015 | 30 | 0.480 |
Why?
|
| Vaccination | 3 | 2021 | 222 | 0.470 |
Why?
|
| Meconium | 2 | 2018 | 2 | 0.470 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2015 | 2 | 0.470 |
Why?
|
| Bryopsida | 3 | 2021 | 3 | 0.470 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2015 | 8 | 0.460 |
Why?
|
| Ventilators, Mechanical | 1 | 2015 | 10 | 0.460 |
Why?
|
| Intubation, Intratracheal | 1 | 2015 | 27 | 0.460 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 42 | 0.450 |
Why?
|
| Spleen | 1 | 2015 | 114 | 0.420 |
Why?
|
| Adjuvants, Immunologic | 2 | 2007 | 68 | 0.410 |
Why?
|
| Animals | 19 | 2021 | 10806 | 0.400 |
Why?
|
| Hepatocytes | 2 | 2003 | 97 | 0.360 |
Why?
|
| Rats | 9 | 2017 | 1595 | 0.350 |
Why?
|
| African Swine Fever | 1 | 2011 | 1 | 0.340 |
Why?
|
| African Swine Fever Virus | 1 | 2011 | 1 | 0.340 |
Why?
|
| Peptidomimetics | 1 | 2011 | 3 | 0.340 |
Why?
|
| Sus scrofa | 1 | 2011 | 12 | 0.340 |
Why?
|
| Apoptosis | 1 | 2015 | 784 | 0.340 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 434 | 0.330 |
Why?
|
| Viral Proteins | 1 | 2011 | 63 | 0.330 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 22 | 0.320 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2003 | 79 | 0.320 |
Why?
|
| Cell Adhesion | 1 | 2010 | 139 | 0.310 |
Why?
|
| Infant, Newborn | 4 | 2018 | 932 | 0.310 |
Why?
|
| Protease Inhibitors | 2 | 2010 | 40 | 0.310 |
Why?
|
| Avian Sarcoma Viruses | 2 | 1999 | 4 | 0.300 |
Why?
|
| RNA-Directed DNA Polymerase | 2 | 1999 | 6 | 0.290 |
Why?
|
| Kidney | 3 | 2007 | 290 | 0.290 |
Why?
|
| Laminin | 2 | 2007 | 21 | 0.280 |
Why?
|
| Epithelial Cells | 1 | 2010 | 272 | 0.280 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2007 | 7 | 0.260 |
Why?
|
| Peptidoglycan | 1 | 2007 | 47 | 0.250 |
Why?
|
| Rubella | 1 | 2026 | 1 | 0.240 |
Why?
|
| Mumps | 1 | 2026 | 2 | 0.240 |
Why?
|
| Diphtheria | 1 | 2026 | 7 | 0.240 |
Why?
|
| Measles | 1 | 2026 | 8 | 0.240 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 697 | 0.240 |
Why?
|
| Deoxyribonucleases | 1 | 2005 | 6 | 0.230 |
Why?
|
| Acetylcysteine | 1 | 2005 | 24 | 0.230 |
Why?
|
| Ascitic Fluid | 1 | 2005 | 11 | 0.220 |
Why?
|
| Proteins | 2 | 2018 | 256 | 0.210 |
Why?
|
| Acholeplasma laidlawii | 3 | 2022 | 3 | 0.210 |
Why?
|
| Papio | 2 | 2021 | 81 | 0.200 |
Why?
|
| Antibodies, Viral | 2 | 2021 | 81 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 79 | 0.200 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 1057 | 0.190 |
Why?
|
| Antigens, Heterophile | 1 | 2003 | 2 | 0.190 |
Why?
|
| Bacterial Proteins | 2 | 2022 | 505 | 0.190 |
Why?
|
| Killer Cells, Natural | 2 | 2001 | 73 | 0.190 |
Why?
|
| Heat-Shock Proteins, Small | 1 | 2022 | 1 | 0.190 |
Why?
|
| Liver | 2 | 2003 | 497 | 0.190 |
Why?
|
| Humans | 11 | 2026 | 29211 | 0.180 |
Why?
|
| Infant | 2 | 2026 | 1067 | 0.180 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 242 | 0.170 |
Why?
|
| Plant Immunity | 1 | 2021 | 5 | 0.170 |
Why?
|
| Acridines | 1 | 2001 | 3 | 0.170 |
Why?
|
| Virus Replication | 1 | 2021 | 66 | 0.170 |
Why?
|
| alpha-Crystallins | 2 | 2011 | 2 | 0.170 |
Why?
|
| Animals, Newborn | 2 | 2017 | 183 | 0.160 |
Why?
|
| Male | 9 | 2026 | 14126 | 0.160 |
Why?
|
| Viral Fusion Proteins | 1 | 2019 | 2 | 0.150 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1362 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2019 | 39 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 417 | 0.150 |
Why?
|
| Mice | 4 | 2015 | 4870 | 0.150 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 111 | 0.150 |
Why?
|
| Child | 2 | 2026 | 2354 | 0.150 |
Why?
|
| Plant Growth Regulators | 1 | 2019 | 9 | 0.140 |
Why?
|
| Oxylipins | 1 | 2019 | 8 | 0.140 |
Why?
|
| Cell Membrane | 3 | 2007 | 268 | 0.140 |
Why?
|
| Glycoproteins | 1 | 2019 | 124 | 0.140 |
Why?
|
| Female | 6 | 2026 | 15825 | 0.140 |
Why?
|
| Acetates | 1 | 2019 | 45 | 0.140 |
Why?
|
| Amniotic Fluid | 1 | 2018 | 6 | 0.140 |
Why?
|
| Cyclopentanes | 1 | 2019 | 17 | 0.140 |
Why?
|
| Electromagnetic Fields | 1 | 1998 | 14 | 0.140 |
Why?
|
| Heat-Shock Proteins | 2 | 2011 | 38 | 0.140 |
Why?
|
| Gastropoda | 1 | 2018 | 2 | 0.140 |
Why?
|
| Spermatogenesis | 1 | 2018 | 11 | 0.140 |
Why?
|
| Amino Acids | 1 | 1998 | 85 | 0.140 |
Why?
|
| Spermatozoa | 1 | 2018 | 34 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2019 | 78 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2007 | 1024 | 0.130 |
Why?
|
| Intestines | 1 | 2018 | 121 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 200 | 0.130 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2007 | 50 | 0.130 |
Why?
|
| Interleukin-2 | 1 | 1997 | 35 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2017 | 163 | 0.120 |
Why?
|
| Lymphocytes | 1 | 1997 | 96 | 0.120 |
Why?
|
| Exhalation | 1 | 2015 | 2 | 0.120 |
Why?
|
| Respiratory Dead Space | 1 | 2015 | 2 | 0.120 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2015 | 8 | 0.120 |
Why?
|
| Tidal Volume | 1 | 2015 | 6 | 0.120 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 200 | 0.120 |
Why?
|
| Respiration | 1 | 2015 | 45 | 0.120 |
Why?
|
| Models, Anatomic | 1 | 2015 | 25 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2010 | 417 | 0.110 |
Why?
|
| Immunoblotting | 3 | 2011 | 124 | 0.110 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2015 | 3 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 168 | 0.110 |
Why?
|
| Equipment Design | 1 | 2015 | 218 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 314 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 35 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2015 | 21 | 0.110 |
Why?
|
| Subclavian Artery | 1 | 2015 | 14 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2015 | 58 | 0.110 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 74 | 0.110 |
Why?
|
| Cyclophosphamide | 1 | 2015 | 44 | 0.110 |
Why?
|
| Pregnancy | 1 | 2018 | 1260 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2021 | 1502 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2007 | 120 | 0.100 |
Why?
|
| Stents | 1 | 2015 | 121 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 77 | 0.100 |
Why?
|
| Dimerization | 2 | 2007 | 76 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2007 | 83 | 0.100 |
Why?
|
| Cell Line | 2 | 2010 | 705 | 0.100 |
Why?
|
| Escherichia coli | 4 | 2019 | 342 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 360 | 0.090 |
Why?
|
| Lung | 1 | 2015 | 389 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2007 | 430 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 80 | 0.090 |
Why?
|
| Antibodies | 1 | 2012 | 125 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2005 | 122 | 0.080 |
Why?
|
| Injections | 1 | 2011 | 31 | 0.080 |
Why?
|
| Body Temperature | 1 | 2011 | 30 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2012 | 114 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2013 | 234 | 0.080 |
Why?
|
| Gentian Violet | 1 | 2010 | 3 | 0.080 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2010 | 5 | 0.080 |
Why?
|
| Genome, Plant | 2 | 2021 | 27 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2011 | 288 | 0.080 |
Why?
|
| Swine | 1 | 2011 | 238 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2010 | 97 | 0.080 |
Why?
|
| Hemolymph | 1 | 2009 | 1 | 0.080 |
Why?
|
| Snails | 1 | 2009 | 5 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 57 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 392 | 0.080 |
Why?
|
| Axons | 1 | 2009 | 30 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 466 | 0.080 |
Why?
|
| Heart Atria | 1 | 2009 | 177 | 0.070 |
Why?
|
| Myocardium | 1 | 2009 | 197 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 131 | 0.070 |
Why?
|
| Myoblasts, Skeletal | 1 | 2007 | 5 | 0.060 |
Why?
|
| Armenia | 1 | 2026 | 1 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2026 | 11 | 0.060 |
Why?
|
| Immunity, Herd | 1 | 2026 | 3 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 99 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 278 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2007 | 191 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 208 | 0.060 |
Why?
|
| Chromatography, Agarose | 1 | 2005 | 3 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 50 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2026 | 277 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 114 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2007 | 828 | 0.050 |
Why?
|
| Diethylnitrosamine | 1 | 2003 | 1 | 0.050 |
Why?
|
| p-Dimethylaminoazobenzene | 1 | 2003 | 1 | 0.050 |
Why?
|
| Fluorometry | 1 | 2003 | 8 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 667 | 0.050 |
Why?
|
| Carcinogens | 1 | 2003 | 39 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2026 | 1013 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2022 | 13 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2026 | 1215 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2003 | 586 | 0.040 |
Why?
|
| K562 Cells | 1 | 2001 | 20 | 0.040 |
Why?
|
| Chitosan | 1 | 2021 | 34 | 0.040 |
Why?
|
| Middle Aged | 2 | 2026 | 7495 | 0.040 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1999 | 1 | 0.040 |
Why?
|
| Templates, Genetic | 1 | 1999 | 10 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1999 | 14 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 26 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1999 | 32 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 614 | 0.040 |
Why?
|
| Adult | 2 | 2026 | 8130 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 303 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 1999 | 151 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 32 | 0.040 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2019 | 75 | 0.040 |
Why?
|
| Immune Sera | 1 | 1999 | 22 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2019 | 68 | 0.040 |
Why?
|
| Cyclotrons | 1 | 1998 | 11 | 0.040 |
Why?
|
| Bacillus subtilis | 1 | 2019 | 23 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1998 | 60 | 0.040 |
Why?
|
| Young Adult | 1 | 2026 | 2877 | 0.040 |
Why?
|
| Adolescent | 1 | 2026 | 3255 | 0.040 |
Why?
|
| Mothers | 1 | 2019 | 126 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2018 | 34 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 151 | 0.030 |
Why?
|
| Kinetics | 1 | 1999 | 553 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 383 | 0.030 |
Why?
|
| Species Specificity | 1 | 2018 | 197 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1997 | 2 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1997 | 39 | 0.030 |
Why?
|
| Culture Media | 1 | 1997 | 99 | 0.030 |
Why?
|
| Random Allocation | 1 | 1997 | 152 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1997 | 170 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1997 | 161 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 669 | 0.030 |
Why?
|
| Russia | 1 | 2015 | 6 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 328 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2013 | 7 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2013 | 5 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2013 | 25 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2013 | 14 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2013 | 27 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2013 | 48 | 0.020 |
Why?
|
| Catalase | 1 | 2013 | 52 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 153 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 72 | 0.020 |
Why?
|
| Glutathione | 1 | 2013 | 77 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 581 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 146 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2012 | 14 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 73 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 177 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 381 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 281 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 112 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 228 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 234 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2011 | 88 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 389 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2015 | 643 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2009 | 5 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 325 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 479 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2009 | 256 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 692 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 5648 | 0.010 |
Why?
|